1. Home
  2. CNM vs EXAS Comparison

CNM vs EXAS Comparison

Compare CNM & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNM
  • EXAS
  • Stock Information
  • Founded
  • CNM 1996
  • EXAS 1995
  • Country
  • CNM United States
  • EXAS United States
  • Employees
  • CNM N/A
  • EXAS N/A
  • Industry
  • CNM Durable Goods
  • EXAS Medical Specialities
  • Sector
  • CNM Consumer Discretionary
  • EXAS Health Care
  • Exchange
  • CNM Nasdaq
  • EXAS Nasdaq
  • Market Cap
  • CNM 10.8B
  • EXAS 9.1B
  • IPO Year
  • CNM 2021
  • EXAS N/A
  • Fundamental
  • Price
  • CNM $62.62
  • EXAS $47.76
  • Analyst Decision
  • CNM Buy
  • EXAS Strong Buy
  • Analyst Count
  • CNM 11
  • EXAS 20
  • Target Price
  • CNM $60.00
  • EXAS $70.26
  • AVG Volume (30 Days)
  • CNM 1.9M
  • EXAS 2.3M
  • Earning Date
  • CNM 09-03-2025
  • EXAS 08-06-2025
  • Dividend Yield
  • CNM N/A
  • EXAS N/A
  • EPS Growth
  • CNM 1.17
  • EXAS N/A
  • EPS
  • CNM 2.16
  • EXAS N/A
  • Revenue
  • CNM $7,611,000,000.00
  • EXAS $2,828,128,000.00
  • Revenue This Year
  • CNM $6.32
  • EXAS $14.61
  • Revenue Next Year
  • CNM $5.03
  • EXAS $12.65
  • P/E Ratio
  • CNM $29.02
  • EXAS N/A
  • Revenue Growth
  • CNM 10.80
  • EXAS 11.57
  • 52 Week Low
  • CNM $37.22
  • EXAS $39.97
  • 52 Week High
  • CNM $65.97
  • EXAS $72.83
  • Technical
  • Relative Strength Index (RSI)
  • CNM 52.05
  • EXAS 39.13
  • Support Level
  • CNM $59.00
  • EXAS $46.06
  • Resistance Level
  • CNM $65.97
  • EXAS $49.57
  • Average True Range (ATR)
  • CNM 1.32
  • EXAS 1.84
  • MACD
  • CNM -0.24
  • EXAS -0.33
  • Stochastic Oscillator
  • CNM 51.94
  • EXAS 19.34

About CNM Core & Main Inc.

Core & Main Inc is a specialty distributor focusing on water, wastewater, storm drainage, and fire protection products and services. Catering to municipalities, private water companies, and contractors, it serves municipal, non-residential, and residential markets nationwide. Its diverse product line includes pipes, valves, fittings, storm drainage products, fire protection products, and meter products. Revenue is principally generated from pipes, valves, and fittings. The company operates across three construction sectors: municipal, non-residential, and residential, contributing to reliable infrastructure development nationwide.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: